Genomewide linkage analyses were conducted of serum creatinine, estimated GFR (eGFR), and urine albumin-creatinine ratio (UACR) in search of genetic susceptibility loci for chronic kidney disease in 1351 black (median age 63 yr, 70% women, 79% hypertensive) and 1022 white individuals (median age 61 yr, 56% women, 75% hypertensive) from sibships in which two or more members had essential hypertension diagnosed before age 60 yr. After adjustment for gender, age, diabetes, and use of angiotensin inhibitors, the logarithm-transformed measure of serum creatinine was heritable in both ethnic groups (0.45 in black individuals [P < 0.001]; 0.39 in white individuals [P < 0.001]), as was eGFR (0.52 in black individuals [P < 0.001]; 0.39 in white individuals [P < 0.001]). Log UACR was heritable in black individuals (0.30, P < 0.001) but not in white individuals (0.12; P ‫؍‬ 0.059). In black individuals, the univariate maximum multipoint logarithm of odds scores (MLS) were observed on chromosome 7 for log serum creatinine (MLS ‫؍‬ 3.65, at 43 cM from pter; P ‫؍‬ 0.00002) and eGFR (MLS ‫؍‬ 2.52, at 45 cM from pter; P ‫؍‬ 0.00033) and for log UACR (MLS ‫؍‬ 2.91, at 112 cM from pter; P ‫؍‬ 0.00012). In white individuals, only one MLS for log serum creatinine and one for eGFR achieved the logarithm of odds score criterion for "suggestive" evidence of linkage (2 < MLS < 3), both on chromosome 3 (at 211 and 209 cM, respectively); however, none did so for log UACR. In black individuals, bivariate linkage analyses of log serum creatinine and pulse pressure (i.e., systolic-diastolic BP) provided "suggestive" evidence of a region on chromosome 5 with pleiotropic effects on both traits (MLS ‫؍‬ 3.62, at 85 cM from pter; P ‫؍‬ 0.00023). These findings support the utility of genetic linkage analyses for identification of novel risk factors that influence measures of chronic kidney disease, particularly among black individuals.
C hronic kidney disease (CKD), defined by albuminuria or reduced estimated GFR (eGFR), afflicts 11% of the adult US population (1) . In the large percentage of cases, which occur in the setting of hypertension or diabetes, arteriosclerosis seems to be a major pathogenic mechanism (2) . However, susceptibility to CKD varies considerably among individuals with known risk factors, suggesting a role for genetic factors other than those that influence BP, glycemia, or other conventional risk factors for arteriosclerosis. This has been demonstrated in animal models (3) and suggested in humans by the disproportionate burden of ESRD among black individuals that may not be explained by greater prevalence or severity of hypertension or diabetes (4) .
The Genetic Epidemiology Network of Arteriopathy (GENOA) and the Family Blood Pressure Program (FBPP) conducted genomewide linkage and association studies to identify genes that influence BP and the cerebral, cardiac, and peripheral vascular complications of hypertension in black and white GENOA sibships in which two or more members received a diagnosis of essential hypertension before age 60 (5) . This study was undertaken to extend those efforts by localizing genomic regions that influence measures of CKD, specifically serum creatinine concentration and urine albumin-creatinine ratio (UACR), in this cohort at increased risk for CKD as a result of the high prevalence of hypertension (6) . Equations that are recommended for estimation of GFR use coefficients for serum creatinine, age, gender, and race that were derived from samples with established kidney disease (7) , an exclusion criterion in GENOA. These coefficients seem to be inaccurate in individuals without known kidney disease, as recruited into GENOA (8) . Therefore, we analyzed serum creatinine in preference to eGFR but stratified by race and adjusted for age and gender within racial groups.
We first performed genomewide univariate linkage analyses for serum creatinine and UACR, followed by bivariate linkage analyses of both measures of CKD and of each measure of CKD with (1) a measure of steady-state BP level (i.e., mean arterial pressure) and (2) a measure of the pulsatile component of BP (i.e., pulse pressure). Measures of BP level and pulsation are influenced by genetic factors (9) and contribute independently to the prediction of CKD (10) . Because bivariate linkage analyses have greater power to identify loci with effects that are too small to be detected in single trait analyses (11), we sought to localize additional genes with pleiotropic effects on measures of CKD, beyond what could be accomplished by univariate linkage analyses of serum creatinine or UACR alone.
Materials and Methods
The 1351 black individuals (952 women, 399 men) and 1022 nonHispanic white individuals (575 women, 447 men) were members of sibships that initially enrolled in the GENOA study of the FBPP between July 1997 and August 1999 (6) . In Jackson, Mississippi, sibships were recruited through hypertensive probands from the Atherosclerosis Risk in Communities cohort, a probability sample of 45-to 64-yr-old black residents of that community. In Rochester, Minnesota, the Mayo Clinic diagnostic index and medical record linkage system of the Rochester Epidemiology Project were used to identify non-Hispanic white residents of Olmsted County who had a diagnosis of essential hypertension made before age 60 yr (12) . Sibships in which either of the index hypertensive siblings was known to have impaired kidney function (e.g., serum creatinine Ն2.0 mg/dl) were not recruited. Otherwise, at both sites, all available members of the index sibships were invited to participate in an initial study visit. 
Study Protocol
Height was measured by a wall stadiometer, weight was measured by electronic balance, and body mass index was calculated in units of kg/m 2 . BP was measured with a random zero sphygmomanometer (Hawksley and Sons, West Sussex, England) and a cuff that was appropriate for arm size. The second and third of three readings, taken from the right arm after the participant sat for at least 5 min, were averaged for the analyses. Mean arterial pressure was calculated as ([SBP] ϩ 2 ϫ [DBP])/3, where SBP is systolic BP and DBP is diastolic BP, and pulse pressure was calculated as (SBP Ϫ DBP). In addition to the rationale for bivariate linkage analyses of measures of CKD and BP (discussed above), an additional rationale for 547 (41) 523 (51) a Data are median (interquartile range) for quantitative traits or n (%) for categorical traits. Number of black individuals with measurements of serum creatinine ϭ 1338, urine albumin-creatinine ratio ϭ 1351; number of white individuals with serum creatinine ϭ 1022, urine albumin-creatinine ratio ϭ 958. The prevalence of elevated serum creatinine was defined by values Ͼ97.5th percentile for gender-specific normals, reduced eGFR by values Ͻ60 ml/min per 1.73 m 2 , and elevated UACR by values Ͼ95th percentile for gender-specific normals (47) . BMI, body mass index; DBP, diastolic BP; eGFR, estimated GFR; MAP, mean arterial pressure; RAS, renin-angiotensin system; SBP, systolic BP; UACR, urine albumin-creatinine ratio.
analysis of pulse pressure, specifically, was the high percentage of GENOA participants who were treated with antihypertensive medications (see Table 1 ), which may lower both SBP and DBP levels but have less impact on the calculated difference between them (9). Each prescription medication recorded at the study visit was assigned a code that was based on mechanism of action. The diagnosis of hypertension was confirmed when a previous diagnosis of hypertension and use of prescription antihypertensive medication were reported or when the average SBP or DBP was Ն140 or Ն90 mmHg, respectively. Diabetes was diagnosed when the participant reported treatment with insulin or oral hypoglycemic agents, or the serum glucose concentration (fasting) was Ն126 mg/dl.
Laboratory Measurements
Blood was drawn after an overnight fast of at least 8 h, and urine was collected on the morning of the study visit. Serum creatinine, glucose, total cholesterol, HDL cholesterol, and triglyceride concentrations and urine albumin, total protein, and creatinine concentrations were measured by standard methods on a Hitachi 911 Chemistry Analyzer (Roche Diagnostics, Indianapolis, IN) (13, 14) . The eGFR was calculated using the Modification of Diet in Renal Disease (MDRD) equation: eGFR ϭ 186.3 ϫ (serum creatinine)
Ϫ1.154 ϫ (age) Ϫ0.203 ϫ (0.742 if female) ϫ (1.212 if black) (7, 15) .
For calibration with the Cleveland Clinic assay that was used to develop the MDRD equation, 0.22 mg/dl (17 mol/L) was added to all serum creatinine values. This adjustment for calibration bias was based on 255 serum creatinine samples that were measured both with the GENOA rate-Jaffe assay and with the Cleveland Clinic rate-Jaffe assay (on a Beckman CX3; Beckman Coulter, Fullerton, CA). A set of 381 microsatellite markers distributed across the 22 autosomes (CHLC/Weber screening set 9.0) was genotyped by PCR methods by the Mammalian Genotyping Center (Marshfield, WI), which provided the ordering of markers and their genetic map distances.
Statistical Analyses
Heritability was defined as the proportion of variance explained by additive genetic factors relative to the residual phenotypic variance after adjustment within each ethnic group for the covariates gender, age, diabetes, and use of angiotensin inhibitors (angiotensin-converting enzyme inhibitors and angiotensin receptor blockers). Genetic correlations between covariate-adjusted measures of the renal and BP traits were estimated by variance decomposition using maximum likelihood methods. Univariate and bivariate quantitative linkage analyses were performed using a variance components approach implemented in the multic S-Plus library as described previously (16, 17) . The multipoint identity-by-descent probabilities of allele sharing among pairs of relatives within each ethnic group were calculated using the SIMWALK2 software program (18) . Within each ethnic group, trait measures were adjusted for the same covariates as in the heritability analyses by incorporating these covariates in the genetic models.
In the univariate linkage analyses, we considered multipoint maximum logarithm of odds (LOD) scores (MLS) Ն3.00 as statistically significant evidence of linkage, Ն2.00 as suggestive evidence of linkage, and Ͼ1.30 as tentative evidence of linkage (19) . These MLS thresholds correspond to P values of 0.0001, 0.001, and 0.007, respectively. To achieve levels of statistical significance in the bivariate linkage analyses comparable to the univariate thresholds, we considered bivariate MLS Ն4.00 as statistically significant evidence of linkage (P Յ 0.0001), Ն2.87 as suggestive evidence (P Յ 0.001), and Ն2.06 as tentative evidence of linkage (P Յ 0.007). We inferred evidence of chromosomal regions with pleiotropic effects on a pair of traits when the bivariate MLS for the combination of traits met the LOD score criteria for evidence of linkage and its nominal P value was less than that associated with either univariate MLS in the same region. Because the greater statistical power of bivariate over univariate linkage analysis depends on the genetic correlation between traits, adjustment of either trait to remove variation that was attributable to the other would be expected to reduce the evidence of linkage. Therefore, to support further the loci that were reported as having pleiotropic effects on renal traits, we conducted additional analyses to confirm that the univariate MLS for the renal trait indeed was reduced by additional adjustment for the other (covariate) trait.
Results
The black sample of 1351 individuals included 166 sibships of size Ն3, 211 sibships of size 2, and 304 sibships of size 1, which provided 1180 sibling pairs. The white sample of 1022 individuals included 136 sibships of size Ն3, 222 sibships of size 2, and 52 sibships of size 1, which provided 1113 sibling pairs. Women composed 70% of the black and 56% of the white individuals. Consistent with the recruitment schema, Ͼ70% of individuals in each ethnic group had hypertension, and Ͼ70% were treated with BP-lowering medications. Other descriptive characteristics are summarized in Table 1 .
After adjustment for gender, age, diabetes, and use of angiotensin inhibitors, the estimated heritability was highest for log serum creatinine and eGFR in black individuals (0.45 Ϯ 0.07 and 0.52 Ϯ 0.07, respectively), followed by log serum creatinine and eGFR in white individuals (0.39 Ϯ 0.07 for both traits) and log UACR in black individuals (0.31 Ϯ 0.07). Whereas each of these heritability estimates was significantly greater than zero (P Յ 0.0001), the estimated heritability of log UACR in white individuals was not (0.12 Ϯ 0.07; P ϭ 0.06). Additional adjustments for body mass index and smoking changed heritability estimates by Ͻ0.02 (data not shown) and were not considered in the linkage analyses presented next.
In the univariate linkage analyses, the maximum MLS for log serum creatinine met the criterion for significant evidence of linkage (MLS Ն 3.0) in black individuals on chromosome 7 (MLS ϭ 3.65 at 43 cM from pter; P ϭ 0.00002; Table 2 , Figure 1) . The greatest MLS for log UACR in black individuals was also observed on chromosome 7 (MLS ϭ 2.91 at 112 cM from pter; P ϭ 0.00012). In white individuals, the greatest LOD score was observed for log serum creatinine on chromosome 3 (MLS ϭ 2.21 at 211 cM from pter; P ϭ 0.00071; Table 3 ). Only one MLS for log UACR achieved the minimum threshold for "tentative" evidence of linkage (MLS ϭ 1.95 at 76 cM from pter; P ϭ 0.00136; Table 4 ), consistent with its nonsignificant heritability in white individuals. Univariate linkage analyses of eGFR demonstrated extensive overlap and parallelism of the LOD score plots and essentially identical location of MLS peaks with those for log serum creatinine (Tables 2 and 3 ; Supplemental Figures, available online at www.jasn.org).
The bivariate linkage analyses provided evidence of numerous loci with pleiotropic effects on pairwise combinations of log serum creatinine, log UACR, and pulse pressure (Table 5) . Most notable was a region of chromosome 5q in black individuals, where the univariate linkage analyses for log serum creatinine and pulse pressure each demonstrated "suggestive" evidence of linkage (i.e., univariate MLS ϭ 2.00 to 2.99; Figure 2) . Here, at 85 cM from 5pter, the bivariate MLS rose to a value of 3.65 (P ϭ 0.00023), which also satisfied the bivariate criteria for "suggestive" evidence of linkage.
Discussion
The univariate MLS for log serum creatinine achieved statistical significance on a genomewide basis on chromosome 7p in black individuals. In this same region, Bowden et al. (20) reported a LOD score of similar magnitude for diabetic nephropathy (at 33 cM from 7pter), and Fox et al. (21) reported weak evidence of linkage for eGFR based on serum creatinine (see Figure 1 legend) . Plausible candidate genes in this region that may influence CKD susceptibility include integrin ␤ 8, IL-6, and neuropeptide Y. The most compelling of these positional candidate genes seems to be IL-6 (at 36 cM from 7pter). Along with its soluble receptor, IL-6 plays a central role in regulation of inflammatory processes, including progression of CKD. In particular, IL-6 levels have been positively correlated with BP levels (22) and with progressive loss of kidney function (23) . Moreover, polymorphic variation in the IL-6 gene has been associated with numerous risk factors for CKD, including obe- Figure 1 . Univariate logarithm of odds (LOD) score plots for log serum creatinine and log urine albumin-creatinine ratio on chromosome 7 in black individuals. Letters locate previously reported linkage peaks for nephropathies (N) and measures of BP (P), and subscripts index references listed in parentheses: N 1 (20) , N 2 (28) , N 3 (39), P 1 (49), P 2 (49,50), P 3 (49), and P 4 (29) . sity, insulin resistance, type 2 diabetes, atherogenic dyslipidemia, and myocardial infarction (24 -27) .
The peak univariate MLS for log UACR also was observed in black individuals on chromosome 7 (at 112 cM from 7pter), and it nearly achieved statistical significance on a genomewide basis. This region was identified previously in univariate linkage analyses for diabetic nephropathy (28), pulse pressure (29), and myocardial infarction (30) (see Figure 1 legend) . The paraoxonase genes PON1, PON2, and PON3 (at 106 to 108 cM from 7pter) are the only obvious candidate genes for albuminuria in this region. Serum paraoxonase is an esterase that is associated with HDL and may confer protection against arteriosclerosis by destroying proinflammatory oxidized lipids in LDL (31) . PON1 polymorphisms have been found to influence serum paraoxonase levels and therefore may affect the development of arteriosclerosis and inflammatory response (32) . Moreover, polymorphisms in the PON1 and PON2 genes have been associated with the risk for diabetic nephropathy (33, 34) and progression of focal sclerosing glomerulopathy (35) .
Bivariate linkage analyses provided "suggestive" evidence that genes in the chromosome 5q13-14 region may have pleiotropic effects on log serum creatinine and pulse pressure (Figure 2 ). This region was identified previously in univariate linkage analyses for pulse pressure in Mexican Americans (29) . However, to the best of our knowledge, no measure of kidney damage or function previously has been linked to or associated with markers in this region, and none of the genes in the region is an obvious candidate to influence BP or kidney disease.
DeWan et al. (36) conducted a genome scan for renal clearance of creatinine measured in 466 black and 634 white hypertensive siblings from the Hypertension Genetic Epidemiology Network (HyperGen) of the FBPP. The best evidence for linkage was found on chromosome 3, both in white (at 115 cM from 3pter) and in black individuals (at 215 cM from 3pter). In our samples, "suggestive" evidence of linkage for serum creatinine was observed in the latter region in white individuals (at 211 cM from 3pter) and more proximally in black individuals (at 67 cM from 3pter). Other genome scans for measures of kidney function or nephropathy also have implicated these and additional regions of chromosome 3 (20, 21, (37) (38) (39) . Such multiplicity of linkage evidence from independent studies suggests that chromosome 3 may harbor numerous genes that influence kidney function or CKD susceptibility.
In the only previous genome scan for log UACR in hypertensive families, Freedman et al. (14) reported "suggestive" evidence of linkage on chromosome 12 (at 112 cM from pter) and on chromosome 19 (at 9 cM from pter) in the HyperGen cohort. Although HyperGen, like GENOA, ascertained sibships in which two or more siblings had essential hypertension diagnosed before age 60 yr, the HyperGen linkage analysis was conducted after pooling the black and white cohorts. Our analyses of GENOA data identified "tentative" evidence of linkage for albuminuria on chromosome 12 (at 57 cM from pter in black individuals) and on chromosome 19 (at 100 cM from pter in white individuals); however, the considerable distances from the loci that were identified in the HyperGen analysis do not support replication.
In two previous genomewide scans for serum creatinine concentration, both in cohorts representative of white individuals, the strongest evidence of linkage was observed on chromosomes 2 (at 145 cM from 2pter) (40) and 4 (at 176 cM from 4pter) (41) . In our study, no linkage peaks for log serum creatinine were observed in either of these regions. Moreover, we found no evidence of linkage for serum creatinine or for albuminuria in the chromosome 10q24-q26 region that corresponds to the rodent renal failure locus, RF-1 (42). This region had been implicated in early linkage analyses of small samples of black siblings with ESRD (43) and in white pedigrees with repeated measurements of creatinine clearance (44) but not in subsequent linkage analyses for serum creatinine or albuminuria reported in the larger HyperGen cohorts (14) . A major limitation of this and previous linkage studies to localize CKD genes relates to measurement of the disease phenotype(s). eGFR that are based on serum creatinine or creatinine clearance are only modestly correlated with measured GFR (r approximately 0.50 to 0.75), (45) , and UACR is not perfectly correlated with albumin excretion rate (46) . Because the phenotypes that we analyzed are influenced by factors that may have different genetic regulation (e.g., creatinine production and tubular excretion [47] ), our findings may not be specific for glomerular filtration or albumin excretion rate. An additional limitation is that impaired kidney function was an exclusion criterion for GENOA, which may have limited the range of variation in serum creatinine or UACR and reduced the power to detect linkage. Indeed, the estimated heritability of log UACR was not significantly greater than zero in white individuals, and calculations indicated that the power to detect quantitative trait loci exceeded 50% in only two locations for log serum creatinine (on chromosomes 3 and 5) and in no locations for log UACR (Supplemental Table 2 ). Consequently, many MLS provided only "tentative" or "suggestive" Univariate and bivariate LOD score plots for log serum creatinine and pulse pressure on chromosome 5 in black individuals. Letters locate previously reported linkage peaks for measures of BP (P), and subscripts index references listed in parentheses: P 1 (50) and P 2 (29) .
evidence of linkage for not only UACR but also serum creatinine. Even for black individuals, in whom the power to detect a locus that influences log serum creatinine on chromosome 7 exceeded 90% (online Table 1 ) and the MLS for serum creatinine achieved genomewide significance, the implicated chromosomal region was broad and included multiple genes. Therefore, replication of this peak in an independent sample would be prudent before attempting to determine which positional candidate genes may be responsible for the observed linkage. Finally, our samples included only black and white sibships with Ն2 members who had a diagnosis of essential hypertension before 60 yr of age; consequently, extension of inferences to groups of different ethnicity or background predisposition to CKD may be limited. Deaths as a result of cardiac and cerebral complications of arteriosclerosis (e.g., heart attack, stroke) are decreasing; however, as the population ages, the incidence of ESRD is rising and contributing to the mounting costs for dialysis or kidney transplantation. Cross-sectional and longitudinal studies that have demonstrated a relationship between CKD and risk factors for arteriosclerosis, including high BP, hyperglycemia, and dyslipidemia, have suggested the possibility that CKD and arteriosclerosis may have common, shared genetic pathways (2) . For the most part, results of our study are more consistent with the notion of CKD susceptibility genes that are distinct from those that influence BP (48) .
